| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $6.3B | $5.2B | $1.2B | $0.8B | $0.7B | $3.6B |
| Cost of Revenue | $3.7B | $3.8B | $4.2B | $3.5B | $2.7B | $2.1B | $2.4B | $2.7B |
| Gross Profit | $2.2B | $2.2B | $2.1B | $1.7B | $0.3B | $0.2B | $0.2B | $1.0B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.6B | $0.4B | $0.7B | $0.0B | $0.1B | $0.1B | $0.3B |
| Net Income | $0.3B | $0.2B | $-0.1B | $0.5B | $-0.0B | $0.1B | $0.0B | $0.2B |
| EPS (Basic) | $4.22 | $2.96 | $-0.87 | $7.33 | $-0.07 | $1.24 | $0.90 | $5.30 |
| EPS (Diluted) | $4.20 | $2.94 | $-0.87 | $7.29 | $-0.07 | $1.23 | $0.89 | $5.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.9B | $14.0B | $15.4B | $10.3B | $10.3B | $4.6B | $4.4B | $4.6B |
| Current Assets | $2.7B | $2.8B | $3.4B | $3.0B | $2.7B | $1.9B | $1.6B | $1.8B |
| Cash & Equivalents | $0.5B | $0.4B | $0.6B | $0.7B | $0.7B | $0.6B | $0.3B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.3B | $1.2B | $1.3B | $1.0B | $1.1B | $0.8B | $0.6B | $0.7B |
| Stockholders' Equity | $6.8B | $6.3B | $6.3B | $6.4B | $6.3B | $2.5B | $2.4B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.6B | $0.7B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.1B | $0.3B | $-5.0B | $-0.1B | $-0.2B | $-0.0B | $0.1B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.8B | $-1.1B | $4.2B | $-0.3B | $-0.1B | $-0.1B | $-0.4B | $-0.0B |